Proactive compliance reviews of promotional materials may help reduce regulatory risk as FDA continues to monitor this evolving market. Rebecca Zadaka, Associate Attorney, Gardner Law How Gardner Law Can Help FDAs recent warning letters underscore the regulatory risk associated with compounded GLP-1 marketing, particularly where promotional claims overstate product status, safety, effectiveness, or comparability to approved drugs
In just three months, GLP-1 users appear to have moved from researching whether creatine is safe to actively choosing gummies as the format
Type 2 diabetes Treatment summaries
GLP3 Mechanism of Action GLP3 peptide exerts its biological effects through balanced activation of three G-protein-coupled receptors that collectively regulate metabolic homeostasis
CookUnity Business | Recipe created on: 6/8/2026 How Self-Insured Employers Are Managing the Cost of GLP-1 Coverage Learn how self-insured employers are managing rising GLP-1 drug costs with structured coverage policies, nutrition programs, and population health strategies